Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
28,736,767
-
Number of holders
-
56
-
Total 13F shares, excl. options
-
13,953,489
-
Shares change
-
-12,765,477
-
Total reported value, excl. options
-
$83,162,048
-
Value change
-
-$76,091,712
-
Put/Call ratio
-
23.9%
-
Number of buys
-
54
-
Number of sells
-
-2
-
Price
-
$5.96
Significant Holders of GeneDx Holdings Corp. - Common Stock (WGS) as of Q2 2023
63 filings reported holding WGS - GeneDx Holdings Corp. - Common Stock as of Q2 2023.
GeneDx Holdings Corp. - Common Stock (WGS) has 56 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 13,953,489 shares
of 28,736,767 outstanding shares and own 48.6% of the company stock.
Largest 10 shareholders include Corvex Management LP (3,307,523 shares), Casdin Capital, LLC (3,095,511 shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (1,253,895 shares), ORACLE INVESTMENT MANAGEMENT INC (865,849 shares), Blackstone Inc. (835,062 shares), MARSHALL WACE, LLP (761,159 shares), Soleus Capital Management, L.P. (711,396 shares), VANGUARD GROUP INC (678,933 shares), GAGNON SECURITIES LLC (363,567 shares), and BlackRock Inc. (263,301 shares).
This table shows the top 56 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.